Synergistic combination to overcome immunotherapy resistance in MSS-type CRC. Ferroptosis inducers directly kill cells and release DAMPs (e.g., HMGB1) to activate anti-tumor immunity. This evidence concerns the gene HMGB1 and neoplasm.